I thought that these were a few important points to mention in the most advanced test in our pipeline (PromarkerD) that already has CE mark approval for Mass Spectrometry, IVD test & online Hub for test interpretation in the EU. It’s not a matter of “selling a few tests”, this space in Diabetes & prevention of CKD & CVD is transformational now with the research coming out.
I think if you aren’t happy to be patient & hold @no vice, it may be better if you sell or keep your frustrations to yourself. Many of us have been holding for years & enjoying the progress made with Johnson & Johnson (Janssen).
In case you weren’t aware, Biotech investment, especially in diagnostics involved with a major International Pharma, is no five minute blow job.
GLTAH
Ann: Partnership with QIMR Berghofer targets oesophageal cancer, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $58.92M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 35.0¢ | $6.88K | 19.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 6523 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 17020 | 3 |
View Market Depth
| Last trade - 13.03pm 01/08/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |